These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 18375114

  • 1. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells.
    Hashimoto I, Koizumi K, Tatematsu M, Minami T, Cho S, Takeno N, Nakashima A, Sakurai H, Saito S, Tsukada K, Saiki I.
    Eur J Cancer; 2008 May; 44(7):1022-9. PubMed ID: 18375114
    [Abstract] [Full Text] [Related]

  • 2. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL, Zhang JL, Tang SF, Fu QY, Li ZT.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 15; 88(3):202-5. PubMed ID: 18361822
    [Abstract] [Full Text] [Related]

  • 3. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
    Yasumoto K, Yamada T, Kawashima A, Wang W, Li Q, Donev IS, Tacheuchi S, Mouri H, Yamashita K, Ohtsubo K, Yano S.
    Clin Cancer Res; 2011 Jun 01; 17(11):3619-30. PubMed ID: 21482691
    [Abstract] [Full Text] [Related]

  • 4. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P, Mateo J.
    Oncogene; 2009 Jan 22; 28(3):313-24. PubMed ID: 18978810
    [Abstract] [Full Text] [Related]

  • 5. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
    Tsuboi K, Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Nakayama G, Koike M, Fujiwara M, Yamamura Y, Nakao A.
    Oncol Rep; 2008 Nov 22; 20(5):1117-23. PubMed ID: 18949410
    [Abstract] [Full Text] [Related]

  • 6. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.
    Woodard J, Sassano A, Hay N, Platanias LC.
    Clin Cancer Res; 2008 Jul 15; 14(14):4640-9. PubMed ID: 18628479
    [Abstract] [Full Text] [Related]

  • 7. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML.
    Prostate; 2006 Jan 01; 66(1):32-48. PubMed ID: 16114056
    [Abstract] [Full Text] [Related]

  • 8. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
    Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y.
    Mol Pharmacol; 2007 Jul 01; 72(1):29-39. PubMed ID: 17395690
    [Abstract] [Full Text] [Related]

  • 9. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer.
    Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O, Saiki I.
    Cancer Res; 2006 Feb 15; 66(4):2181-7. PubMed ID: 16489019
    [Abstract] [Full Text] [Related]

  • 10. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.
    Clements D, Markwick LJ, Puri N, Johnson SR.
    J Immunol; 2010 Aug 01; 185(3):1812-21. PubMed ID: 20585037
    [Abstract] [Full Text] [Related]

  • 11. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE.
    Ann Clin Lab Sci; 2006 Aug 01; 36(3):283-93. PubMed ID: 16951269
    [Abstract] [Full Text] [Related]

  • 12. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
    Grozinsky-Glasberg S, Franchi G, Teng M, Leontiou CA, Ribeiro de Oliveira A, Dalino P, Salahuddin N, Korbonits M, Grossman AB.
    Neuroendocrinology; 2008 Aug 01; 87(3):168-81. PubMed ID: 18025810
    [Abstract] [Full Text] [Related]

  • 13. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK, Lee JJ, Yang Y, You KH, Lee JH.
    Carcinogenesis; 2008 Apr 01; 29(4):704-12. PubMed ID: 18258606
    [Abstract] [Full Text] [Related]

  • 14. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
    Dobashi Y, Suzuki S, Matsubara H, Kimura M, Endo S, Ooi A.
    Cancer; 2009 Jan 01; 115(1):107-18. PubMed ID: 19090006
    [Abstract] [Full Text] [Related]

  • 15. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
    Chen GS, Yu HS, Lan CC, Chow KC, Lin TY, Kok LF, Lu MP, Liu CH, Wu MT.
    Br J Dermatol; 2006 May 01; 154(5):910-8. PubMed ID: 16634895
    [Abstract] [Full Text] [Related]

  • 16. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
    Tan CT, Chu CY, Lu YC, Chang CC, Lin BR, Wu HH, Liu HL, Cha ST, Prakash E, Ko JY, Kuo ML.
    Carcinogenesis; 2008 Aug 01; 29(8):1519-27. PubMed ID: 18487224
    [Abstract] [Full Text] [Related]

  • 17. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.
    Cancer Res; 2009 Jul 15; 69(14):5793-800. PubMed ID: 19584281
    [Abstract] [Full Text] [Related]

  • 18. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, Kim S, Jo DY.
    Int J Oncol; 2009 Feb 15; 34(2):473-80. PubMed ID: 19148483
    [Abstract] [Full Text] [Related]

  • 19. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O, Almazan G.
    J Neurochem; 2009 Jun 15; 109(5):1440-51. PubMed ID: 19453943
    [Abstract] [Full Text] [Related]

  • 20. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
    Kawajiri H, Yashiro M, Shinto O, Nakamura K, Tendo M, Takemura S, Node M, Hamashima Y, Kajimoto T, Sawada T, Ohira M, Hirakawa K.
    Clin Cancer Res; 2008 May 01; 14(9):2850-60. PubMed ID: 18451253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.